Can we stop AIDS with antiretroviral-based treatment as prevention?

Mills, E.J.; Nachega, J.B.; Ford, N.

Global Health Science and Practice 1(1): 29-34

2013


ISSN/ISBN: 2169-575X
PMID: 25276515
DOI: 10.9745/ghsp-d-12-00053
Document Number: 566838
Challenges to scaling up treatment as prevention (TasP) of HIV transmission are considerable in the developing-world context and include accessing at-risk populations, human resource shortages, adherence and retention in care, access to newer treatments, measurement of treatment effects, and long-term sustainable funding. Optimism about ending AIDS needs to be tempered by the realities of the logistic challenges of strengthening health systems in countries most affected and by balancing TasP with overall combination prevention approaches.

Document emailed within 0-6 h
Secure & encrypted payments